MAPT and early-onset autosomal dominant Alzheimer disease: Therefore, the gBOLD-CSF coupling may serve as a marker for evaluating the glymphatic function, and was linked to Aβ and tau in Alzheimer's disease, Parkinson's disease, as well as aging (44–48).